SeqBiome is delighted to expand the executive team with Dr Jim Collins as our new Chief Operating Officer! Jim has over 20 years of international experience in the development and scale-up of genome analysis technologies for genetic testing applications. Prior to joining SeqBiome, he led the development and deployment of sequencing-based tests with a focus on women’s health at Invitae, a genetic testing company based in San Francisco. Before that, Jim directed the development of technologies for non-invasive prenatal screening at Singular Bio (acquired by Invitae) and CellScape and platform technologies for genomic analysis at Complete Genomics, Affymetrix and Agilent. Jim holds BSc and PhD degrees in Microbiology from University College Cork.